[Cytogenetic analysis of secondary myelodysplastic syndrome after rhabdomysarcoma treatment--case report].
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Alveolar subtype of RMS is characterized by very poor prognosis and intensive chemotherapy, radiotherapy and surgery often failed. Frequently a secondary malignant neoplasms has been found in patients treated for primary cancer. Ten-years-old boy with RMS in the right thigh after 3 years of treatment revealed therapy related myelodysplastic syndrome and was lost to follow-up 4 months later.